Skip to content

Ali J Zarrabi

Emory Center for Psychedelics and Spirituality, Emory University, Atlanta, GA, USA. ali.zarrabi@emoryhealthcare.org.

2 papers in the library · 14 citations · publishing 2025-2026

Papers

A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.

Psychotherapy January 13, 2025 Roman Palitsky, Jessica L Maples-Keller, Caroline Peacock et al. 13 citations

In an open-label trial of psilocybin-assisted therapy for cancer-related demoralization and chronic pain, patients, facilitators, and caregivers identified key components and improvements for the treatment protocol. Using the Enhanced Critical Incident Technique, interviews revealed critical incidents, wish list items, and contributing factors related to therapy aspects like intention-setting and overall protocol transitions. The findings emphasize tailoring treatment to individual medical history, supporting common therapeutic factors, and ensuring collaborative care. Nine topic areas for protocol improvement emerged from the data.

Attitudes of U.S. Muslims Toward Psychedelics.

Psychedelic medicine (New Rochelle, N.Y.) March 1, 2026 Syed F Rab, Salman S Ahmad, Roman Palitsky et al. 1 citation

Muslims living in the United States show moderate openness to psychedelic therapies, and a weak negative correlation exists between their rejection of mental health services and their acceptance of psychedelics. Higher education is associated with more favorable attitudes toward both mental health services and psychedelic therapies. The findings highlight the need to understand educational and cultural factors shaping these views to advance equitable mental health care for this underrepresented group.